Clinical trial

Adaptive Chemotherapy for the Treatment of Advanced Breast Cancer

NCT07088263

Study summary

ClinicalTrials.gov

Adaptive Chemotherapy for the Treatment of Advanced Breast Cancer

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Gemcitabine, Vinorelbine, Eribulin, or Utidelone Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-09-15

PhasePHASE3

Conditions

Breast Neoplasmsunresolved

Interventions

Gemcitabine, Vinorelbine, Eribulin, or UtideloneDRUG

Sponsors & collaborators

Sun Yat-sen Universitylead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07088263 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.